Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun
Abstract
The transformation suppressor gene Pdcd4 (programmed cell death gene 4) inhibits the tumor-promoter mediated transformation of mouse keratinocytes and has recently been implicated as a potential tumor suppressor gene in the development of human lung cancer. Biochemical analysis has suggested that the Pdcd4 protein is involved in protein translation as well as in nuclear events. Recent work has shown that Pdcd4 suppresses the transactivation of AP-1 responsive promoters by c-Jun, suggesting that the transformation-suppressor activity of Pdcd4 might be due, at least in part, to the inhibition of c-Jun activity. Here, we have addressed how Pdcd4 inhibits c-Jun. We show that Pdcd4 interferes with the phosphorylation of c-Jun by Jun N-terminal kinase (JNK). The inhibition of c-Jun phosphorylation by Pdcd4 appears not to be due to a general suppression of JNK activity, our data rather suggest that Pdcd4 interacts with c-Jun and thereby blocks phosphorylation of c-Jun. In addition to affecting c-Jun phosphorylation, Pdcd4 blocks the recruitment of the coactivator p300 by c-Jun. Taken together, our results strongly suggest that Pdcd4 is directly involved in the regulation of c-Jun activity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
PDCD4 inhibits activation of c-Jun by suppressing JNK activation in avian QT6 cells.
“PDCD4 was shown to inhibit the activation of c-Jun by suppressing the JNK-activation in avian QT6 cells [34] and to suppress the expression of the upstream kinase MAP4K1 in RKO human colon carcinoma cells [33].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [34]
Cites
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188 · see citing works
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886 · see citing works
Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., & Livingston, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.8.869 · Cited by 1,045 · see citing works
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 928 · see citing works
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789 · see citing works
Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain
Binétruy, B., Smeal, T., & Karin, M. (1991) · Nature · doi:10.1038/351122a0 · Cited by 598 · see citing works
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works
c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions
Kallunki, T., Deng, T., Hibi, M., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81999-6 · Cited by 492 · see citing works
The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene
Ness, S. A., Marknell, Å., & Graf, T. (1989) · Cell · doi:10.1016/0092-8674(89)90767-8 · Cited by 453 · see citing works
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail
Moscovici, C., Moscovici, M. G., Jimenez, H., Lai, M. M. C., Hayman, M. J., & Vogt, P. K. (1977) · Cell · doi:10.1016/0092-8674(77)90320-8 · Cited by 402 · see citing works
Interaction and functional collaboration of p300 and C/EBPβ
Mink, S., Haenig, B., & Klempnauer, K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6609 · Cited by 344 · see citing works
Self-citationLoss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
Chen, Y., Knösel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I., & Petersen, I. (2003) · The Journal of Pathology · doi:10.1002/path.1378 · Cited by 265 · see citing works
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254 · see citing works
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223 · see citing works
Yang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · see citing works
Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185 · see citing works
Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4
Young, M. R., Yang, H., & Colburn, N. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00009-6 · Cited by 167 · see citing works
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160 · see citing works
Lee, J.-S., See, R. H., Deng, T., & Shi, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4312 · Cited by 153 · see citing works
JNK phosphorylation relieves HDAC3‐dependent suppression of the transcriptional activity of c‐Jun
Weiss, C., Schneider, S., Wagner, E. F., Zhang, X. M., Seto, E., & Bohmann, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg364 · Cited by 150 · see citing works
c-Jun NH2-terminal Kinases Target the Ubiquitination of Their Associated Transcription Factors
Fuchs, S. Y., Xie, B., Adler, V., Fried, V. A., Davis, R. J., & Ronai, Z. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32163 · Cited by 141 · see citing works
Intramolecular signal transduction in c‐Jun.
Papavassiliou, A. G., Treier, M., & Bohmann, D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07193.x · Cited by 125 · see citing works
Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity
Schwartz, C., Schachtrup, K., Mink, S., Schmolke, M., Budde, B., Wenning, D., & Klempnauer, K.-H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg076 · Cited by 122 · see citing works
Self-citationThe transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA
Böhm, M., Sawicka, K., Siebrasse, J. P., Brehmer-Fastnacht, A., Peters, R., & Klempnauer, K.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206710 · Cited by 101 · see citing works
Self-citationProgrammed cell death protein 4 (pdcd4): A novel target for antineoplastic therapy?
Lankat–Buttgereit, B., & Göke, R. (2003) · Biology of the Cell · doi:10.1016/j.biolcel.2003.09.003 · Cited by 94 · see citing works
Interaction of C/EBPβ and v-Myb Is Required for Synergistic Activation of the mim -1 Gene
Mink, S., Kerber, U., & Klempnauer, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1316 · Cited by 94 · see citing works
Self-citationDUG is a novel homologue of translation initiation factor 4G that binds eIF4A
Göke, A., Göke, R., Knolle, A., Trusheim, H., Schmidt, H., Wilmen, A., Carmody, R. J., Göke, B., & Chen, Y. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02129-0 · Cited by 92 · see citing works
Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II
Lankat–Buttgereit, B., Gregel, C. M., Knolle, A., Hasilík, A., Arnold, R., & Göke, R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.058 · Cited by 75 · see citing works
Yoshinaga, H., Matsuhashi, S., Fujiyama, C., & Masaki, Z. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00995.x · Cited by 62 · see citing works
Up-regulation of PDCD4 in senescent human diploid fibroblasts
Kang, M.-J., Ahn, H.-S., Lee, J.-Y., Matsuhashi, S., & Park, W.-Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00264-4 · Cited by 57 · see citing works
The chicken Pdcd4 gene is regulated by v-Myb
Schlichter, U. H. A., Burk, O., Worpenberg, S., & Klempnauer, K.-H. (2001) · Oncogene · doi:10.1038/sj.onc.1204071 · Cited by 53 · see citing works
Self-citationCarbonic anhydrase II is an AP‐1 target gene in osteoclasts
David, J. ‐., Rincón, M., Neff, L., Horne, W. C., & Baron, R. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1099 · Cited by 50 · see citing works
Targeted disruption of c-myb in the chicken pre B-cell line DT40
Appl, H., & Klempnauer, K.-H. (2002) · Oncogene · doi:10.1038/sj.onc.1205427 · Cited by 21 · see citing works
Self-citationIdentification of the myb-inducible promoter of the chicken Pdcd4 gene
Schlichter, U., Kattmann, D., Appl, H., Miethe, J., Brehmer-Fastnacht, A., & Klempnauer, K.-H. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(01)00252-4 · Cited by 20 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882 · see citing works
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987 · see citing works
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011) · Bioscience Reports · doi:10.1042/bsr20100065 · Cited by 332 · see citing works
The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation
Lankat–Buttgereit, B., & Göke, R. (2009) · Biology of the Cell · doi:10.1042/bc20080191 · Cited by 307 · see citing works
Stagakis, E., Bertsias, G. K., Verginis, P., Νάκου, Μ., Hatziapostolou, M., Kritikos, H. D., Iliopoulos, D., & Boumpas, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139857 · Cited by 301 · see citing works
Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer
Shibuya, H., Iinuma, H., Shimada, R., Horiuchi, A., & Watanabe, T. (2010) · Oncology · doi:10.1159/000323283 · Cited by 244 · see citing works
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
Talotta, F., Cimmino, A., Matarazzo, M. R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., & Verde, P. (2009) · Oncogene · doi:10.1038/onc.2008.370 · Cited by 242 · see citing works
Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
Sheth, S., Jajoo, S., Kaur, T., Mukherjea, D., Sheehan, K., Rybak, L. P., & Ramkumar, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051655 · Cited by 225 · see citing works
Yang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202 · see citing works
Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H., & Allgayer, H. (2007) · Cancer · doi:10.1002/cncr.22983 · Cited by 196 · see citing works
Rapid Culling of the CD4+ T Cell Repertoire in the Transition from Effector to Memory
Williams, M. A., Ravkov, E. V., & Bevan, M. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.014 · Cited by 168 · see citing works
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma
Liu, C., Yu, J., Yu, S., Lavker, R. M., Cai, L., Liu, W., Yang, K.-G., He, X., & Chen, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.021 · Cited by 164 · see citing works
Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163 · see citing works
Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein
Palamarchuk, A., Efanov, A., Maximov, V., Aqeilan, R. I., Croce, C. M., & Pekarsky, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3469 · Cited by 151 · see citing works
Wang, Q., Sun, Z., & Yang, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210793 · Cited by 147 · see citing works
Wang, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.1682 · Cited by 146 · see citing works
Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143 · see citing works
Reis, P. P., Tomenson, M., Cervigne, N. K., Machado, J., Jurišica, I., Pintilie, M., Sukhai, M. A., Perez‐Ordoñez, B., Grenman, R. A., Gilbert, R. W., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-238 · Cited by 142 · see citing works
Fish, J. E., & Marsden, P. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5421-8 · Cited by 138 · see citing works
Shiota, M., Izumi, H., Tanimoto, A., Takahashi, M., Miyamoto, N., Kashiwagi, E., Kidani, A., Hirano, G., Masubuchi, D., Fukunaka, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2334 · Cited by 134 · see citing works
Zhen, Y., Liu, Z., Yang, H., Yu, X., Wu, Q., Hua, S., Long, X., Jiang, Q., Song, Y., Cheng, C., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.376 · Cited by 131 · see citing works
Nakata, K., Sugi, Y., Narabayashi, H., Kobayakawa, T., Nakanishi, Y., Tsuda, M., Hosono, A., Kaminogawa, S., Hanazawa, S., & Takahashi, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.788596 · Cited by 132 · see citing works
Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Chu, J., Cargnello, M., Topisirović, I., & Pelletier, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.005 · Cited by 127 · see citing works
Papavassiliou, A. G., & Musti, A. M. (2020) · Cells · doi:10.3390/cells9112470 · Cited by 122 · see citing works
Park, Y. M., Hwang, S. J., Masuda, K., Choi, K.-M., Jeong, M., Nam, D., Gorospe, M., & Kim, H. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00443-12 · Cited by 125 · see citing works
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer
Mori (2010) · International Journal of Oncology · doi:10.3892/ijo_00000590 · Cited by 124 · see citing works
Pdcd4, a colon cancer prognostic that is regulated by a microRNA
Allgayer, H. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.09.001 · Cited by 123 · see citing works
The role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113 · see citing works
Wu, H., Kong, L., Tan, Y., Epstein, P. N., Zeng, J., Gu, J., Liang, G., Kong, M., Chen, X., Miao, L., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3958-8 · Cited by 101 · see citing works
Frequent loss of PDCD4 expression in human glioma: Possible role in the tumorigenesis of glioma
Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W., & Zhang, L. (2007) · Oncology Reports · doi:10.3892/or.17.1.123 · Cited by 100 · see citing works
Miyanaga, A., Gemma, A., Noro, R., Kataoka, K., Matsuda, K., 奈良, 道., Okano, T., Seike, M., Yoshimura, A., Kawakami, A., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2140 · Cited by 99 · see citing works
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Zhai, Y., Wang, T., Fu, Y., Yu, T., Ding, Y. P., & Nie, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098011 · Cited by 96 · see citing works
Yang, Y., Meng, H., Peng, Q., Yang, X., Gan, R., Zhao, L., Chen, Z., Lu, J., & Meng, Q. H. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2014.66 · Cited by 94 · see citing works
The Links between Transcription, β-catenin/JNK Signaling, and Carcinogenesis
Saadeddin, A., Babaei‐Jadidi, R., Spencer‐Dene, B., & Nateri, A. S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0027 · Cited by 85 · see citing works
Sensing the scent of death: Modulation of microRNAs by curcumin in gastrointestinal cancers.
Ashrafizadeh, M., Zarrabi, A., Hashemipour, M., Massoud Vosough, M. P., Najafi, M., Shahinozzaman, M., Hushmandi, K., Khan, H., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105199 · Cited by 77 · see citing works
Targeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 80 · see citing works
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
Izzo, S., Naponelli, V., & Bettuzzi, S. (2020) · Nutrients · doi:10.3390/nu12041010 · Cited by 79 · see citing works
Dikshit, B., Irshad, K., Madan, E., Aggarwal, N., Sarkar, C., Chandra, P. S., Gupta, D. K., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2012) · Oncogene · doi:10.1038/onc.2012.393 · Cited by 79 · see citing works
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer
Wei, N., Liu, S. S., Leung, T. H., Tam, K., Liao, X. Y., Cheung, A., Chan, K. K. L., & Ngan, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-70 · Cited by 79 · see citing works
The Role of microRNA-21 in the Onset and Progression of Cancer
Singh, A. K., Singh, A. K., Giri, R., Kumar, D., Sharma, R., Vališ, M., Kuča, K., & Garg, N. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0096 · Cited by 77 · see citing works
MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases
Li, S., Liang, Z., Liu, X., & Zou, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1052-6 · Cited by 76 · see citing works
PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis
Fassan, M., Pizzi, M., Giacomelli, L., Mescoli, C., Ludwig, K., Pucciarelli, S., & Rugge, M. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1046-5 · Cited by 76 · see citing works
Tumor Suppressor Protein Pdcd4 Inhibits Translation of p53 mRNA
Wedeken, L., Singh, P., & Klempnauer, K.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269456 · Cited by 75 · see citing works
Self-citationsiRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression
Bitomsky, N., Wethkamp, N., Marikkannu, R., & Klempnauer, K.-H. (2008) · Oncogene · doi:10.1038/onc.2008.115 · Cited by 75 · see citing works
Self-citationYang, F., Liu, M., Li, W., Che, J., WANG, G.-C., & Zheng, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2813 · Cited by 74 · see citing works
PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis
Ludwig, K., Fassan, M., Mescoli, C., Pizzi, M., Balistreri, M., Albertoni, L., Pucciarelli, S., Scarpa, M., Sturniolo, G. C., Angriman, I., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1345-5 · Cited by 67 · see citing works
Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
Santhanam, A. N., Baker, A. R., Hegamyer, G., Kirschmann, D. A., & Colburn, N. H. (2010) · Oncogene · doi:10.1038/onc.2010.158 · Cited by 67 · see citing works
Gao, F., Wang, X., Zhu, F., Wang, Q., Zhang, X., Guo, C., Zhou, C., Ma, C., Sun, W., Zhang, Y., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00497.x · Cited by 66 · see citing works
MicroRNA-21 suppression impedes medulloblastoma cell migration
Grunder, E., D’Ambrosio, R., Fiaschetti, G., Abela, L., Arcaro, A., Zuzak, T. J., Ohgaki, H., Lv, S., Shalaby, T., & Grotzer, M. A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.041 · Cited by 65 · see citing works
Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
Wang, G., Wang, J. J., Tang, H., & To, S. S. T. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.001 · Cited by 63 · see citing works
Luo, X., Gu, J., Zhu, R., Feng, M., Zhu, X., Li, Y., & Fei, J. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-82 · Cited by 62 · see citing works
Xia, H., & Zhao, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1699826 · Cited by 61 · see citing works
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
Wei, N., Liu, S. S., Chan, K. K. L., & Ngan, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030311 · Cited by 58 · see citing works
Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation
Singh, P., Wedeken, L., Waters, L. C., Carr, M. D., & Klempnauer, K.-H. (2011) · Oncogene · doi:10.1038/onc.2011.202 · Cited by 50 · see citing works
Self-citationHwang, S.-K., Baker, A. R., Young, M. R., & Colburn, N. H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu008 · Cited by 49 · see citing works
MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Liu, R., Liu, C., He, X., Sun, P., Zhang, B., Yang, H., Shi, W., & Ruan, Q. (2022) · Nature Communications · doi:10.1038/s41467-022-31317-0 · Cited by 48 · see citing works
Waters, L. C., Veverka, V., Böhm, M., Schmedt, T., Choong, P. T., Muskett, F. W., Klempnauer, K.-H., & Carr, M. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210305 · Cited by 48 · see citing works
Self-citationNedaeinia, R., Sharifi, M., Avan, A., Kazemi, M., Nabinejad, A., Ferns, G. A., Ghayour-Mobarhan, M., & Salehi, R. (2017) · Tumor Biology · doi:10.1177/1010428317692261 · Cited by 47 · see citing works
Programmed cell death 4 protein in esophageal cancer
Rugge (2010) · Oncology Reports · doi:10.3892/or_00000838 · Cited by 45 · see citing works
Zhen, Y., Li, D., Li, W., Yao, W., Wu, A., Huang, J., Gu, H., Huang, Y., Wang, Y., Wu, J., et al. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14478843952861 · Cited by 42 · see citing works
Effects of quercetin on microRNAs: A mechanistic review
Kordkheyli, V. A., Khonakdar-Tarsi, A., Mishan, M. A., Tafazoli, A., Bardania, H., Zarpou, S., & Bagheri, A. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28663 · Cited by 41 · see citing works
Wang, Q., Zhang, Y., & Yang, H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.004 · Cited by 41 · see citing works
Zhang, X., Wang, X., Song, X., Liu, C., Shi, Y., Wang, Y., Afonja, O., Ma, C., Chen, Y. H., & Zhang, L. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01664.x · Cited by 39 · see citing works
Waters, L. C., Strong, S. L., Ferlemann, E., Oka, O., Muskett, F. W., Veverka, V., Banerjee, S., Schmedt, T., Henry, A. J., Klempnauer, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166157 · Cited by 37 · see citing works
Self-citationBiyanee, A., Ohnheiser, J., Singh, P., & Klempnauer, K.-H. (2015) · Oncogene · doi:10.1038/onc.2014.83 · Cited by 37 · see citing works
Self-citationInhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis
Rodrigues, P. M., Afonso, M. B., Simão, A. L., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2015) · Scientific Reports · doi:10.1038/srep17528 · Cited by 37 · see citing works
The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury
Wang, X., Zhang, L., Wei, Z., Zhang, X., Gao, Q., Ma, Y., Liu, X., Jiang, Y. Z., Liu, X., Guo, C., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2012.174 · Cited by 36 · see citing works
Fehler, O., Singh, P., Haas, A., Ulrich, D., Müller, J. P., Ohnheiser, J., & Klempnauer, K.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku800 · Cited by 35 · see citing works
Self-citationProgrammed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
Fassan, M., Pizzi, M., Battaglia, G., Giacomelli, L., Parente, P., Bocus, P., Ancona, E., & Rugge, M. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.078253 · Cited by 35 · see citing works
Shen, L., Ling, M., Li, Y., Xu, Y., Zhou, Y., Ye, J., Pang, Y., Zhao, Y., Jiang, R., Zhang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057652 · Cited by 33 · see citing works
Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors
Калиниченко, С. В., Kopantzev, E. P., Korobko, E. V., Palgova, I. V., Эдуардовна, З. Л., Mv, B., Petrov, A. N., Frank, G. A., Sverdlov, E. D., & Korobko, I. V. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.03.022 · Cited by 33 · see citing works
Mladenov, M. I., Bogdanov, J. B., Bogdanov, B., Hadzi‐Petrushev, N., Kamkin, A. G., Stojchevski, R., & Avtanski, D. B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00559-5 · Cited by 32 · see citing works
Wedeken, L., Ohnheiser, J., Hirschi, B., Wethkamp, N., & Klempnauer, K. (2010) · Genes & Cancer · doi:10.1177/1947601910364227 · Cited by 32 · see citing works
Self-citationNedaeinia, R., Avan, A., Ahmadian, M., Nia, S. N., Ranjbar, M., Sharifi, M., Goli, M., Piroozmand, A., Nourmohammadi, E., Manian, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26047 · Cited by 32 · see citing works
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus
Araki, Y., & Mimura, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021019 · Cited by 31 · see citing works
Kumar, N., Wethkamp, N., Waters, L. C., Carr, M. D., & Klempnauer, K.-H. (2013) · Oncogenesis · doi:10.1038/oncsis.2012.37 · Cited by 30 · see citing works
Self-citationChen, B., Huang, S. G., Ju, L., Li, M., Nie, F. F., Zhang, Y., Zhang, Y. H., Chen, X., & Gao, F. (2016) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20155020 · Cited by 30 · see citing works
Iinuma, H. (2012) · Oncology Reports · doi:10.3892/or.2012.1648 · Cited by 30 · see citing works
Fay, M. M., Clegg, J. M., Uchida, K. A., Powers, M. A., & Ullman, K. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.541300 · Cited by 30 · see citing works
PDCD4 Knockdown Induces Senescence in Hepatoma Cells by Up-Regulating the p21 Expression
Guo, J., Ozaki, I., Xia, J., Kuwashiro, T., Kojima, M., Takahashi, H., Ashida, K., Anzai, K., & Matsuhashi, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00661 · Cited by 29 · see citing works
Mechanisms elevating ORMDL3 expression in recurrent wheeze patients: Role of Ets-1, p300 and CREB
Jin, R., Xu, H., Yuan, W.-X., Zhuang, L., Liu, L., Jiang, L., Zhu, L.-H., Liu, J., & Zhou, G.-P. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.007 · Cited by 29 · see citing works
Paolo, A. D., Eastman, G., Mesquita-Ribeiro, R., Farías, J., Macklin, A. M., Kislinger, T., Colburn, N. H., Munroe, D. J., Sosa, J. R. S., Dajas‐Bailador, F., et al. (2020) · RNA · doi:10.1261/rna.075424.120 · Cited by 28 · see citing works
Tang, C., Liu, Y., Liu, S., Yang, C., Chen, L., Tang, F., Wang, F., Zhan, L., Deng, H., Zhou, W., et al. (2021) · Pharmacology · doi:10.1159/000520311 · Cited by 28 · see citing works
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28 · see citing works
Ahn, J., Choi, J., Won, M., Kang, C., Gyun, M.-R., Park, H., Kim, C., & Chung, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.121 · Cited by 26 · see citing works
Kim, C., Won, M., Choi, C.-H., Ahn, J., Kim, B., Song, K.-B., Kang, C., & Chung, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.012 · Cited by 25 · see citing works
Singh, P. A., Marikkannu, R., Bitomsky, N., & Klempnauer, K. H. (2009) · Oncogene · doi:10.1038/onc.2009.239 · Cited by 24 · see citing works
Self-citationChen, Y., Bian, Y., Zhao, S., Kong, F., & Li, X. (2016) · Oncology Letters · doi:10.3892/ol.2016.5323 · Cited by 22 · see citing works
Zhao, J., Cao, J., Zhou, L., Du, Y., Zhang, X., Yang, B., Gao, Y., Wang, Y., Ma, N., & Yang, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.9307 · Cited by 22 · see citing works
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
Jèmaà, M., Abassi, Y., Kifagi, C., Fezai, M., Daams, R., Lang, F. J. W., & Massoumi, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-30251-w · Cited by 21 · see citing works
Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
Reyes‐González, J. M., Quiñones‐Díaz, B. I., Santana‐Rivera, Y., Báez, P., Soto, D., Valiyeva, F., Marcos-Martínez, M. J., Thomas, R. J. F.-D., & Vivas‐Mejía, P. E. (2020) · Cancers · doi:10.3390/cancers12040880 · Cited by 19 · see citing works
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarin
Franchin, C., Salvi, M., Arrigoni, G., & Pinna, L. A. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.04.002 · Cited by 17 · see citing works
Singh, P., Singh, A. P., Tripathi, S. K., Kumar, V., & Sane, A. P. (2019) · Plant Science · doi:10.1016/j.plantsci.2019.110242 · Cited by 15 · see citing works
Matsuhashi, S. (2011) · Oncology Reports · doi:10.3892/or.2011.1450 · Cited by 15 · see citing works
Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation
Kloos, B., Chakraborty, S., Lindner, S. G., Noack, K., Steffen, U., Schett, G. A., Krämer, O. H., & Kubatzky, K. F. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0117-7 · Cited by 15 · see citing works
Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma
Jiang, Y., Zhang, S. H., Han, G. Q., & Qin, C. Y. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.015 · Cited by 14 · see citing works
Pdcd4 tumor suppressor: Properties, functions, and possible applications in oncology
Вихрева, П. Н., Shepelev, M. V., Korobko, E. V., & Korobko, I. V. (2010) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416810020011 · Cited by 13 · see citing works
Lim, S., & Hong, R. (2011) · Oncology Letters · doi:10.3892/ol.2011.365 · Cited by 13 · see citing works
Jo, S.-H., Kim, D. E., Clocchiatti, A., & Dotto, G. P. (2016) · Oncotarget · doi:10.18632/oncotarget.11227 · Cited by 13 · see citing works
Ferris, W. F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903374 · Cited by 12 · see citing works
- Authors
- Bitomsky, N., Böhm, M., & Klempnauer, K.-H.
- Affiliations
- University of Münster (DE)
- Corresponding author
- Klempnauer, Karl-Heinz
- Venue
- Oncogene
- Published
- 2004-08-30
- Volume
- 23
- Issue
- 45
- Pages
- 7484-7493
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2081476178
- Cited by
- 134
- References
- 34
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 10 · 2015: 5 · 2014: 10 · 2013: 5 · 2012: 9
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Krebshilfe
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- PDCD4, c-Jun, JNK, c-Jun phosphorylation, P300, coactivator recruitment, AP-1 transactivation, tumor suppressor, keratinocyte transformation, lung cancer, protein-protein interaction
- MeSH terms
- Animals, Cell Line, Humans, Nuclear Proteins, Phosphorylation, Protein Binding, Quail, Trans-Activators, RNA-Binding Proteins, Proto-Oncogene Proteins c-jun, Mitogen-Activated Protein Kinase Kinases, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Apoptosis Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review